BLCM

Bellicum Pharmaceuticals, Inc. BLCM

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BLCM INFIQ PAVM NVIV IMPL WENA PKBO ACOR PHGE NMTRQ
6M -74.22 % 900.00 % -27.44 % -72.35 % -97.71 % -87.86 % 150.00 % -93.35 % 9.33 % 9 900.00 %
YTD -50.82 % 900.00 % -22.91 % -59.38 % -57.89 % -87.86 % -91.50 % -95.58 % -24.75 % 900.00 %
1Y -76.64 % 0.00 % -52.56 % -67.93 % -98.88 % -87.86 % -71.84 % -96.07 % -39.69 % 900.00 %
3Y -97.97 % -99.99 % -96.78 % -98.90 % -99.73 % -87.86 % -99.77 % -99.21 % -82.42 % -99.99 %
5Y -99.79 % -99.99 % -98.36 % -99.97 % -99.73 % -87.86 % -99.77 % -99.95 % -99.02 % -100.00 %
10Y -99.97 % -100.00 % -99.34 % -100.00 % -99.73 % -87.86 % -99.77 % -99.98 % -99.39 % -100.00 %
From the beginning -99.97 % -100.00 % -99.34 % -100.00 % -99.73 % -87.86 % -99.77 % -99.92 % -99.39 % -100.00 %

Dividend